We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > RIKEN

News List

Fujitsu to study Covid-19 treatments using supercomputer Fugaku pharmaceutical-technology
June 23, 2021
Fujitsu Japan has commenced a new research project to detect and analyse potential Covid-19 drugs by leveraging a fast supercomputer, Fugaku, co-developed by the company and RIKEN.
IIT Guwahati and RIKEN-Japan collaborate for novel approach to separate chiral molecules expresspharma
August 27, 2020
The separation of enantiomers is important in the biomedical field because many biochemically active chemicals are found as mixtures of two enantiomers, one of which may be beneficial and the other, toxic.
Daiichi Sankyo to develop Nafamostat inhalation therapy for Covid-19 pharmaceutical-technology
June 10, 2020
Japanese pharmaceutical company Daiichi Sankyo has signed a basic agreement with the University of Tokyo, Nichi-Iko Pharmaceutical and RIKEN for the research and development (R&D) of a Nafamostat inhalation formulation to treat Covid-19.
Bayer and RIKEN establish partnership for novel drug discovery biospectrumasia
October 09, 2019
100 years of history, RIKEN is Japan’s largest national research organization with over 3,500 employees across 10 research sites including Kobe, Osaka, Tokyo, Harima, Yokohama and Wako.